Review




Structured Review

NextGen Sciences optitype
Optitype, supplied by NextGen Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optitype/product/NextGen Sciences
Average 90 stars, based on 1 article reviews
optitype - by Bioz Stars, 2026-05
90/100 stars

Images



Similar Products

90
NextGen Sciences optitype
Optitype, supplied by NextGen Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optitype/product/NextGen Sciences
Average 90 stars, based on 1 article reviews
optitype - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Origimed Inc optitype was used to identify class i hla (hla-a, hla-b, and hla-c) alleles and class ⅱ hla-drb1 alleles
Optitype Was Used To Identify Class I Hla (Hla A, Hla B, And Hla C) Alleles And Class ⅱ Hla Drb1 Alleles, supplied by Origimed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optitype was used to identify class i hla (hla-a, hla-b, and hla-c) alleles and class ⅱ hla-drb1 alleles/product/Origimed Inc
Average 90 stars, based on 1 article reviews
optitype was used to identify class i hla (hla-a, hla-b, and hla-c) alleles and class ⅱ hla-drb1 alleles - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
NextGen Sciences optitype bcbio-nextgen v.1.1.5
Optitype Bcbio Nextgen V.1.1.5, supplied by NextGen Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optitype bcbio-nextgen v.1.1.5/product/NextGen Sciences
Average 90 stars, based on 1 article reviews
optitype bcbio-nextgen v.1.1.5 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
CeGAT GmbH optitype
Optitype, supplied by CeGAT GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optitype/product/CeGAT GmbH
Average 90 stars, based on 1 article reviews
optitype - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Omixon Inc optitype
(A) <t>HLA-B</t> allele alignment of next generation sequencing data for one sample in HLA Explore software (exons 1–4). This sample resulted in a failure or “no call” for the HLA-B locus; however, by actual HLA typing was found to be HLA-B*44:02:01/*56:01:01. The top row shows the correct alignment of reads (represented by stacked grey bars) to the HLA-B*56:01:01 allele from exon 1 (left side) to exon 4 (right side of diagram), while the middle row shows reads unevenly and incorrectly mapping to the HLA-B*83:01 allele, and the bottom row shows a lack of reads mapping to the correct HLA-B*44:02:01 allele. (B) In contrast, the <t>Optitype</t> plots for the same sample are shown. This software produced a call concordant to the second field for each allele.
Optitype, supplied by Omixon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optitype/product/Omixon Inc
Average 90 stars, based on 1 article reviews
optitype - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


(A) HLA-B allele alignment of next generation sequencing data for one sample in HLA Explore software (exons 1–4). This sample resulted in a failure or “no call” for the HLA-B locus; however, by actual HLA typing was found to be HLA-B*44:02:01/*56:01:01. The top row shows the correct alignment of reads (represented by stacked grey bars) to the HLA-B*56:01:01 allele from exon 1 (left side) to exon 4 (right side of diagram), while the middle row shows reads unevenly and incorrectly mapping to the HLA-B*83:01 allele, and the bottom row shows a lack of reads mapping to the correct HLA-B*44:02:01 allele. (B) In contrast, the Optitype plots for the same sample are shown. This software produced a call concordant to the second field for each allele.

Journal: Human immunology

Article Title: Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type

doi: 10.1016/j.humimm.2020.06.002

Figure Lengend Snippet: (A) HLA-B allele alignment of next generation sequencing data for one sample in HLA Explore software (exons 1–4). This sample resulted in a failure or “no call” for the HLA-B locus; however, by actual HLA typing was found to be HLA-B*44:02:01/*56:01:01. The top row shows the correct alignment of reads (represented by stacked grey bars) to the HLA-B*56:01:01 allele from exon 1 (left side) to exon 4 (right side of diagram), while the middle row shows reads unevenly and incorrectly mapping to the HLA-B*83:01 allele, and the bottom row shows a lack of reads mapping to the correct HLA-B*44:02:01 allele. (B) In contrast, the Optitype plots for the same sample are shown. This software produced a call concordant to the second field for each allele.

Article Snippet: A , Pre-NAC , Concordant , Omixon – No Call (both alleles); Optitype & HLA-Genotyper – Concordant , Concordant , Omixon - No Call (one allele); HLA-Genotyper - Concordant , Concordant , Omixon - No Call (one allele); HLA-Genotyper-Concordant.

Techniques: Next-Generation Sequencing, Software, Produced

Summary of concordance between actual HLA typing by SSO and predicted typing by next generation sequencing by locus. Number (percentage) of alleles (for 68 samples from Data Set 1: Germline Whole Exome Sequencing of Patients with Breast Cancer) is provided. A) Using Omixon software; B) Using  OptiType  software; C) Using  HLA-Genotyper  software. Full results are available in the Supplementary materials .

Journal: Human immunology

Article Title: Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type

doi: 10.1016/j.humimm.2020.06.002

Figure Lengend Snippet: Summary of concordance between actual HLA typing by SSO and predicted typing by next generation sequencing by locus. Number (percentage) of alleles (for 68 samples from Data Set 1: Germline Whole Exome Sequencing of Patients with Breast Cancer) is provided. A) Using Omixon software; B) Using OptiType software; C) Using HLA-Genotyper software. Full results are available in the Supplementary materials .

Article Snippet: A , Pre-NAC , Concordant , Omixon – No Call (both alleles); Optitype & HLA-Genotyper – Concordant , Concordant , Omixon - No Call (one allele); HLA-Genotyper - Concordant , Concordant , Omixon - No Call (one allele); HLA-Genotyper-Concordant.

Techniques: Next-Generation Sequencing, Sequencing, Software

Summary of concordance of  HLA  calls generated by actual  HLA  typing (SSO) and predicted typing by next generation sequencing by locus for tumor specimens of each of the 5 subjects. The tumor from subject A was typed at 4 different time points. Full data is available in the Supplementary materials .

Journal: Human immunology

Article Title: Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type

doi: 10.1016/j.humimm.2020.06.002

Figure Lengend Snippet: Summary of concordance of HLA calls generated by actual HLA typing (SSO) and predicted typing by next generation sequencing by locus for tumor specimens of each of the 5 subjects. The tumor from subject A was typed at 4 different time points. Full data is available in the Supplementary materials .

Article Snippet: A , Pre-NAC , Concordant , Omixon – No Call (both alleles); Optitype & HLA-Genotyper – Concordant , Concordant , Omixon - No Call (one allele); HLA-Genotyper - Concordant , Concordant , Omixon - No Call (one allele); HLA-Genotyper-Concordant.

Techniques: Generated, Next-Generation Sequencing